Cancer center, charity, and cultural references
A new analysis shows a 57% rise in accidents involving dangerous chemicals from 2021 to 2025, with injuries and fatalities climbing. More than 650 incidents have occurred since 2020, affecting millions living near facilities, as regulators face pressure to tighten safety rules amid aging infrastructure.
The FDA has approved daraxonrasib (Rasonque), a once-daily pill from Revolution Medicines, for adults with metastatic pancreatic cancer who have received prior therapy or cannot take combination chemotherapy. A 500‑patient trial has shown median survival of 13.2 months versus 6.7 months for chemotherapy; a 30‑day supply will cost about $39,800 and expanded access has already treated thousands.